Proton magnetic resonance spectroscopy in MRI-negative temporal lobe epilepsy

Neurology

Volumn 51, Issue 1, 1998, Pages 61-66

  Connelly, Alan ^a,b   Van Paesschen, W ^b,c   Porter, D A ^a,b   Johnson, C L ^b   Duncan, J S ^c   Gadian, D G ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE DERIVATIVE; CREATINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPORAL LOBE EPILEPSY;

EID: 0031867906     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.1.61     Document Type: Article

References (38)

1. Crombie DL, Cross KW, Fry RJ, Pinsent RJ, Watts CA. A survey of the epilepsies in general practice: a report of the research committee of the Royal College of General Practitioners. Br Med J 1960;2:416-422.
2. Granieri E, Rosati G, Tola R, et al. A descriptive study of epilepsy in the district of Coppara, Italy, 1964-1978. Epilepsia 1983;24:502-514.
3. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota 1940-1980. Epilepsia 1990;32:429-445.
4. Hauser W. The natural history of temporal lobe epilepsy. In: Luders HA, ed. Epilepsy surgery. New York: Raven Press, 1992:133-141.
5. Babb TL, Brown WJ. Pathological findings in epilepsy. In: Engel J Jr, ed. Surgical treatment of the epilepsies. New York: Raven Press, 1987:511-540.
6. Jackson GD, Berkovic SF, Duncan JS, Connelly A. Optimizing the diagnosis of hippocampal sclerosis using MR imaging. Am J Neuroradiol 1993;14:753-762.
7. Jack CR Jr, Sharbrough FW, Twomey CK, et al. Temporal lobe seizures: lateralization with MR volume measurements of the hippocampal formation. Radiology 1990;175:423-429.
8. Cook MJ, Fish DR, Shorvon SD, Straughan K, Stevens JM. Hippocampal volumetric and morphometric studies in frontal and temporal lobe epilepsy. Brain 1992;115:1001-1015.
9. Bhatia S, Bookheimer SY, Gaillard WD, Theodore WH. Measurements of whole temporal lobe and hippocampus for volumetry: normative data. Neurology 1993;43:2006-2010.
10. Van Paesschen W, Sisodiya S, Connelly A, et al. Quantitative hippocampal MRI and intractable temporal lobe epilepsy. Neurology 1995;45:2233-2240.
11. Van Paesschen W, Connelly A, King MD, Jackson GD, Duncan JS. The spectrum of hippocampal sclerosis: a quantitative magnetic resonance imaging study. Ann Neurol 1997;41:41-51.
12. Jackson GD, Connelly A, Duncan JS, Grunewald RA, Gadian DG. Detection of hippocampal pathology in intractable partial epilepsy: increased sensitivity with quantitative magnetic resonance T2 relaxometry. Neurology 1993;43:1793-1799.
13. Grunewald RA, Jackson GD, Connelly A, Duncan JS. MR detection of hippocampal disease in epilepsy: factors influencing T2 relaxation time. Am J Neuroradiol 1994;15:1149-1156.
14. Van Paesschen W, Connelly A, Johnson CL, Duncan JS. The amygdala and intractable temporal lobe epilepsy: a quantitative magnetic resonance imaging study. Neurology 1996;47: 1021-1031.
15. Koller J, Zaczek R, Coyle J. N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J Neurochem 1984;43: 1136-1142.
16. Moffett J, Namboodiri A, Cangro C, Neale J. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuro Report 1991;2:131-134.
17. Urenjak J, Williams S, Gadian D, Noble M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors and immature oligodendrocytes in vitro. J Neurochem 1992;59:55-61.
18. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981-989.
19. 1H magnetic resonance spectroscopy in the investigation of intractable epilepsy. Acta Neurol Scand 1994;suppl 152:116-121.
20. Connelly A, Jackson GD, Duncan JS, Gadian DG. Proton MRS in temporal lobe epilepsy. Neurology 1994;44:1411-1417.
21. Cendes F, Andermann F, Preul MC, Arnold DL. Lateralization of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images. Ann Neurol 1994;35:211-216.
22. Hugg JW, Laxer KD, Matson GB, Maudsley AA, Weiner MW. Neuron loss localizes human temporal lobe epilepsy by in-vivo proton MR spectroscopic imaging. Ann Neurol 1993;34:788-794.
23. Ng TC, Comair YG, Xue M, et al. Temporal lobe epilepsy: presurgical localisation with proton chemical shift imaging. Radiology 1994;193:465-472.
24. 1H magnetic resonance spectroscopy and T2 relaxometry. Neurology 1995;45: 797-802.
25. Cross JH, Connelly A, Jackson GD, Johnson CL, Neville BGR, Gadian DG. Proton magnetic resonance spectroscopy in children with temporal lobe epilepsy. Ann Neurol 1996;39:107-113.
26. Cendes F, Andermann F, Dubeau F, Arnold DL. Proton magnetic resonance spectroscopic imaging studies for lateralization of temporal lobe epilepsy. Magn Reson Imaging 1995;13: 1187-1191.
27. Hetherington HP, Kuzniecky RI, Pan JW, Vaughan JT, Tweig DB, Pohost GM. Application of high field spectroscopic imaging in the evaluation of temporal lobe epilepsy. Magn Reson Imaging 1995;13:1175-1180.
28. Gadian DG, Isaacs EB, Cross JH, et al. Lateralization of brain function in childhood revealed by magnetic resonance spectroscopy. Neurology 1996;46:974-977.
29. Ende GR, Laxer KD, Knowlton RC, et al. Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging. Radiology 1997;202:809-817.
30. Cendes F, Stanley JA, Dubeau F, Andermann F, Arnold DL. Proton magnetic resonance spectroscopic imaging for discrimination of absence and complex partial seizures. Ann Neurol 1997;41:74-81.
31. Margerison JH, Corsellis JAN. Epilepsy and the temporal lobes: a clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain 1966;89:499-530.
32. Falconer MA. Mesial temporal (Ammon's horn) sclerosis as a common cause of epilepsy: aetiology, treatment and prevention. Lancet 1974;2:767-770.
33. Bruton CJ. The neuropathology of temporal lobe epilepsy. Oxford: Oxford University Press, 1988:1-158.
34. Plummer DL. Displmage, a display and analysis tool for medical images. Rev Neuroradiol 1992;5:489-495.
35. Ordidge RJ, Bendall MR, Gordon RG, Connelly A. Volume selection for in vivo biological spectroscopy. In: Govil, Khetrapal, Saran, eds. Magnetic resonance in biology and medicine. New Delhi: Tata-McGraw-Hill, 1985:387-397.
36. Klose U. In vivo proton spectroscopy in presence of eddy currents. Magn Reson Med 1990;14:26-30.
37. Hoult DI, Richards RE. The signal-to-noise ratio of the nuclear magnetic resonance experiment. J Magn Reson 1976;24:71-85.
38. 1H NMR spectroscopy in Canavan's disease: a report of two cases. Magn Reson Med 1991;19:439-445.